Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received a suspension order for a Drug License from the Assistant Director, Drugs Control Administration, Hubli Circle, Karnataka. The suspension applies to a store located at Ganeshpeth Hubli for a period of three days. The order was received on April 30, 2026, citing violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of Rs 0.97 lakh due to this suspension.
The impact is minimal as it involves only one store suspended for three days with a small estimated revenue loss of less than Rs 1 lakh. This is a routine regulatory compliance matter and is unlikely to have any significant effect on the company's stock or operations.